TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/02/2026
Voltar para busca
Dado oficial do USPTO
SENTRY BIOPHARMA SERVICES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
28/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 39, 42, 45
Data de depósito
01/12/2020
Data de registro
13/02/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/02/2024
Última transação
28/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
US
Examinador
MAHONEY, PAULA M
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized gray wording "SENTRY BIOPHARMA SERVICES" with "BIOPHARMA SERVICES" appearing under the "NTRY" of "SENTRY". To the left of the wording is a stylized yellow design comprised of five large circles, arranged horizontally with a line extending upward to a smaller circle from the right side of the top circle, as well as a line and circle design extending downward from the right side of the third circle and a line and circle design extending leftward from the left side of the fourth circle.
Titulares e representantes
Titulares
Sentry BioPharrna Services, Inc.
Representantes
Kiranjit K Dharsan Seiter IP
Classificação técnica
Classes Nice
Classe 35Classe 39Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Providing business and statistical information and data processing services in the pharmaceuticalbiotechnologymedical devicediagnostics industries; compilationupdating and maintenance of information into computer databases; government relations consultancy services regarding customs clearance for third parties; business administration servicescustoms clearance services for third parties
Classe 39
Supply chain logistics and storage of temperature sensitive healthcare products for the pharmaceuticalbiotechnology and medical device industries in a climate-controlled environment
Classe 42
Providing a web hosting platform for supply chain logistics and freight forwarding services; providing transportation information; electronic data storage services; computer servicesupdating of computer programs
Classe 45
Advice and regulatory compliance consulting in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesdiagnostics
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/02/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/02/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/02/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/06/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/05/2024
FIMP
FINAL DISPOSITION PROCESSED
14/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
13/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/11/2023
PUBO
PUBLISHED FOR OPPOSITION
28/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
27/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/11/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/10/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/04/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/04/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/04/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/09/2022
CNSL
SUSPENSION LETTER WRITTEN
01/09/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
28/11/2021
RFNT
REFUSAL PROCESSED BY IB
29/08/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/08/2021
RFRR
REFUSAL PROCESSED BY MPU
05/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/07/2021
CNRT
NON-FINAL ACTION WRITTEN
27/07/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2021
DOCK
ASSIGNED TO EXAMINER
08/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SENTRY BIOPHARMA SERVICES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.